Skip to main content

Artiva Biotherapeutics, Inc. insider trading

ARTVNASDAQ
$6.83+0.04 (+0.59% today)

“Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise.” — Peter Lynch

Insider Trading vs Stock Price

Insider Trading vs Stock Price data

Showing the 1Y range: Oct 2, 2025 to Oct 2, 2026. Price (+131.5%). 0 insider transactions plotted in this window as 0 markers; nearby trades of the same kind are grouped.

Transactions plotted on the price chart
DateCategoryPersonRoleActionAmountChange in holding
Open market purchase
Open market sell
Marker size reflects transaction size.

Net dollar flow · Buy / Sell balance

Premium
Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26
Unlock quarterly net flow

Key players

  • FAFred AslanChief Executive Officer3.2824%of company
  • JBJennifer BushCOO, CLO, Compliance Officer0.7661%of company
  • CHChristopher HoranChief Tech Operations Officer0.6608%of company
  • TAThad Allen HustonChief Financial Officer0.45%of company
  • SBSubhashis BanerjeeChief Medical Officer0.3497%of company
  • HRHeather RaymonSVP, Research and Development0.3032%of company
  • GDGines Diego MirallesPresident & Head of R&D0.2506%of company
  • NKNeha KrishnamohanChief Financial Officer0.2032%of company
  • TGThorsten GraefChief Medical Officer0.1636%of company
  • RCRA Capital Nexus Fund III, L.P.DirectorNot reportedof company

AI Activity Analysis

Premium
Coming soonAI reads of insider activity will appear here for Premium accounts.

Insider activity

Fromto
CompanyInsider / roleActionΔOwnAvg priceAmount
ARTVFred AslanChief Executive OfficerOpen market sell$256K-1.6%$10.92$256KSep 8, 2026Sep 9, 2026
ARTVChristopher HoranChief Tech Operations OfficerOpen market sell$116K-3.5%$11.16$116KSep 3, 2026Sep 4, 2026
ARTVJennifer BushCOO, CLO, Compliance OfficerOpen market sell$93.6K-2.5%$11.16$93.6KSep 3, 2026Sep 4, 2026
ARTVSubhashis BanerjeeChief Medical OfficerOpen market sell$12.3K-0.8%$11.16$12.3KSep 3, 2026Sep 4, 2026
ARTVFred AslanChief Executive OfficerOpen market sell$690K-4.0%$11.16$690KSep 3, 2026Sep 4, 2026
ARTVRa Capital Management, L.P.DirectorOpen market purchase$248K+0.1%$9.93$248KJul 31, 2026Jul 31, 2026
ARTVRa Capital Management, L.P.DirectorOpen market purchase$208K+0.1%$9.99$208KJul 29, 2026Jul 31, 2026
ARTVRa Capital Management, L.P.DirectorOpen market purchase$413K+0.2%$9.99$413KJul 24, 2026Jul 28, 2026
ARTVRa Capital Management, L.P.DirectorOpen market purchase$596K+0.4%$9.96$596KJul 23, 2026Jul 23, 2026
ARTVRa Capital Management, L.P.DirectorOpen market purchase$835K+0.5%$9.93$835KJul 22, 2026Jul 23, 2026
ARTVRa Capital Management, L.P.DirectorOpen market purchase$1.15M+0.7%$9.55$1.15MJul 21, 2026Jul 23, 2026
ARTVRa Capital Management, L.P.DirectorOpen market purchase$70.5K+0.1%$8.95$70.5KJul 17, 2026Jul 20, 2026
ARTVRa Capital Management, L.P.DirectorOpen market purchase$1.36M+0.9%$8.93$1.36MJul 16, 2026Jul 20, 2026
ARTVRa Capital Management, L.P.DirectorOpen market purchase$58.3K0.0%$8.94$58.3KJul 13, 2026Jul 23, 2026
ARTVRa Capital Management, L.P.DirectorOpen market purchase$58.6K0.0%$8.94$58.6KJul 13, 2026Jul 14, 2026
ARTVRa Capital Management, L.P.DirectorOpen market purchase$135K+0.1%$8.97$135KJul 10, 2026Jul 14, 2026
ARTVRa Capital Management, L.P.DirectorOpen market purchase$16.8K0.0%$8.98$16.8KJun 26, 2026Jun 29, 2026
ARTVRa Capital Management, L.P.DirectorOpen market purchase$275K+0.2%$8.88$275KJun 25, 2026Jun 29, 2026
ARTVPeter KolchinskyDirectorOpen market purchase$1.11M+0.8%$8.89$1.11MJun 16, 2026Jun 16, 2026
ARTVPeter KolchinskyDirectorOpen market purchase$139K+0.1%$8.99$139KJun 15, 2026Jun 16, 2026
ARTVPeter KolchinskyDirectorOpen market purchase$3.35M+2.4%$8.57$3.35MJun 12, 2026Jun 16, 2026
ARTVRA Capital Nexus Fund, L.P.DirectorOpen market purchase$4.34M+3.5%$7.91$4.34MJun 11, 2026Jun 11, 2026
ARTVRA Capital Nexus Fund, L.P.DirectorOpen market purchase$7210.0%$7.00$721Jun 10, 2026Jun 11, 2026
ARTVRA Capital Nexus Fund, L.P.DirectorOpen market purchase$3.31M+3.2%$6.91$3.31MJun 9, 2026Jun 11, 2026
ARTVHeather RaymonSVP, Research and DevelopmentOpen market sell$27.9K-2.1%$9.01$27.9KMay 19, 2026May 19, 2026
ARTVChristopher HoranChief Tech Operations OfficerOpen market sell$63.1K-2.3%$9.01$63.1KMay 19, 2026May 19, 2026
ARTVJennifer BushCOO, CLO, Compliance OfficerOpen market sell$79.2K-2.5%$9.01$79.2KMay 19, 2026May 19, 2026
ARTVSubhashis BanerjeeChief Medical OfficerOpen market sell$63.4K-4.6%$9.01$63.4KMay 19, 2026May 19, 2026
ARTVFred AslanChief Executive OfficerOpen market sell$244K-1.7%$9.01$244KMay 19, 2026May 19, 2026
ARTVGC Corp.10% OwnerOpen market purchase$4M+6.1%$11.52$4MMay 11, 2026May 28, 2026
ARTVGC Corp.10% OwnerOpen market purchase$12.5M+22.1%$11.52$12.5MMay 11, 2026May 28, 2026
ARTVRA Capital Nexus Fund III, L.P.DirectorOpen market purchase$75M+74.9%$11.52$75MMay 11, 2026May 13, 2026
ARTVFred AslanPresident and CEOOpen market sell$19.1K-0.3%$6.00$19.1KDec 15, 2025Dec 15, 2025
ARTVFred AslanPresident and CEOOpen market sell$21.5K-1.8%$3.38$21.5KNov 17, 2025Nov 17, 2025
ARTVFred AslanPresident and CEOOpen market sell$153K-6.7%$6.00$153KOct 17, 2025Oct 17, 2025
End of history · 35 transactions

Not investment advice. We make every effort to keep the information on SpoorBase accurate, but errors may occur. SpoorBase does not guarantee the accuracy or completeness of any data, and any use of the information is at the user’s sole responsibility. Valuation multiples are calculated by SpoorBase and may contain errors. See Disclosures. © 2026 SpoorBase. All rights reserved.